Genetic Phagocyte NADPH Oxidase Deficiency Enhances Nonviable Candida albicans-Induced Inflammation in Mouse Lungs. 2017

Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
Graduate School of Nanobioscience, Yokohama City University, Seto 22-2, Kanazawa, Yokohama, 236-0027, Japan.

Patients with chronic granulomatous disease (CGD) have mutated phagocyte NADPH oxidase, resulting in reduced production of reactive oxygen species (ROS). While the mechanism underlying hyperinfection in CGD is well understood, the basis for inflammatory disorders that arise in the absence of evident infection has not been fully explained. This study aimed to evaluate the effect of phagocyte NADPH oxidase deficiency on lung inflammation induced by nonviable Candida albicans (nCA). Mice deficient in this enzyme (CGD mice) showed more severe neutrophilic pneumonia than nCA-treated wild-type mice, which exhibited significantly higher lung concentrations of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and keratinocyte-derived chemokine (KC). Neutralization of these proinflammatory mediators significantly reduced neutrophil infiltration. In vitro, production of IL-1β and TNF-α from neutrophils and that of KC from macrophages was enhanced in nCA-stimulated neutrophils from CGD mice. Expression of IL-1β mRNA was higher in the stimulated CGD neutrophils than in the stimulated wild-type cells, concomitant with upregulation of nuclear factor (NF)-κB and its upstream regulator extracellular-signal regulated kinase (ERK) 1/2. Pretreatment with an NADPH oxidase inhibitor significantly enhanced IL-1β production in the wild-type neutrophils stimulated with nCA. These results suggest that lack of ROS production because of NADPH oxidase deficiency results in the production of higher levels of proinflammatory mediators from neutrophils and macrophages, which may at least partly contribute to the exacerbation of nCA-induced lung inflammation in CGD mice.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D006105 Granulomatous Disease, Chronic A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern. Autosomal Recessive Chronic Granulomatous Disease,Chronic Granulomatous Disease,Chronic Granulomatous Disease, Atypical,Chronic Granulomatous Disease, X-Linked,Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked,Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked,Granulomatous Disease, Chronic, X-Linked,Granulomatous Disease, Chronic, X-Linked, Variant,X-Linked Chronic Granulomatous Disease,Chronic Granulomatous Disease, X Linked,Chronic Granulomatous Diseases,Granulomatous Diseases, Chronic,X Linked Chronic Granulomatous Disease
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
November 2013, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
January 2013, PLoS pathogens,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
February 2015, Journal of the American Society of Nephrology : JASN,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
May 2008, The American journal of pathology,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
June 2011, Free radical biology & medicine,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
May 2015, Clinical science (London, England : 1979),
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
December 1996, The Journal of toxicological sciences,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
October 2004, Histochemistry and cell biology,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
March 2009, Free radical biology & medicine,
Daiki Endo, and Kenta Fujimoto, and Rika Hirose, and Hiroko Yamanaka, and Mizuki Homme, and Ken-Ichi Ishibashi, and Noriko Miura, and Naohito Ohno, and Yasuaki Aratani
March 2008, Molecular immunology,
Copied contents to your clipboard!